Research Project · Health
Investigator-Initiated Studies (IIS) - Sarepta Therapeutics
Sarepta Therapeuticswww.sarepta.com (opens in a new tab)Catalog updated
- Amount
- Not listed
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
Sarepta Therapeutics funds investigator-initiated studies (IIS) to support independent clinical or non-clinical research that advances precision genetic medicine for rare neuromuscular diseases, providing financial and/or material support aligned with its therapeutic focus. Eligible applicants include individual investigators, institutions, or research groups proposing studies within Sarepta’s core rare disease areas. Proposals are accepted on a rolling basis, reviewed monthly with feedback within 90 days, and require submission of a concept or full proposal through Sarepta Medical Affairs or via IIS@sarepta.com; consult the program FAQ for application requirements, evaluation criteria, and sponsor responsibilities.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 2 similar programs in full.
Ask for a demo of this program The form opens already filled in.